前收市價 | 134.92 |
開市 | 134.68 |
買盤 | 134.94 x 無 |
賣出價 | 135.28 x 無 |
今日波幅 | 133.68 - 134.70 |
52 週波幅 | 132.72 - 160.80 |
成交量 | |
平均成交量 | 13 |
市值 | 無 |
Beta 值 (5 年,每月) | 無 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | 無 |
業績公佈日 | 2024年7月17日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 無 |
A new investor should avoid buying J&J (JNJ) stock right now due to its legal troubles. However, those who already own the stock may stay invested as the company is generating decent sales growth.
Investing in equal parts of these three investments would produce a forward-dividend yield over 3.9%.
Small biotech company Halozyme is behind some of the biggest names in medicine, including Johnson & Johnson's Darzalex and Roche's Tecentriq.